Competitor Meta Ad Spend Estimation — 3 Methods Compared for Healthcare Agencies

Meta does not disclose competitor ad spend for non-political healthcare advertisers in India. That is the honest starting point. Anyone selling you a tool that claims exact-rupee spend for a private IVF clinic in Bangalore is either lying or basing it on a model with error bars they are not showing you. The good news is that reasonable-range estimates are entirely achievable, and three methods are used across the industry — each with different accuracy, cost, and time profiles.

This piece breaks down the three approaches, what accuracy you should expect from each, and which one Prism Spy uses under the hood when it publishes a Top Spenders leaderboard across your healthcare specialty. If you are trying to benchmark your own share of voice or justify a budget increase to a hospital marketing committee, you want to understand this well enough to defend the numbers you present.

Why exact spend is invisible for private healthcare in India

Meta discloses exact ad spend only for two categories in India: political and issue ads, and social-issue advertisers. Everyone else — every hospital, IVF clinic, dental practice, aesthetic centre, hair transplant chain, and pharmaceutical brand — falls outside the disclosure regime. What you can see is the ad creative, the first-seen date, the platforms it runs on, and whether it is currently active. What you cannot see is the money.

This is not a bug from Meta's perspective — it is a deliberate policy protecting commercial confidentiality. It also means every commercial "spy" tool in the market is producing estimates, not disclosures. Understanding the estimation method is how you separate defensible research from vendor theatre.

Method 1: Ad volume × industry CPM benchmarks

The simplest method. Count the number of active ads a competitor has running, multiply by an estimated average CPM (cost per thousand impressions), multiply by an estimated average impressions per ad. All three numbers require assumptions but they can be defended in a spreadsheet.

Typical assumptions in healthcare India in 2026: CPM ranges from ₹80 for a broad Instagram feed placement in a Tier-2 city to ₹450 for a targeted stories placement in metro Delhi or Bangalore. Impressions per ad vary from 15,000 for a low-budget lead generation ad in one city to 500,000+ for a hospital brand campaign running nationally. Multiplying the ranges gets you spend estimates with an accuracy band of roughly plus-or-minus 40 percent.

Method 1 works fine for order-of-magnitude questions. "Is this competitor spending ₹5 lakh a month or ₹50 lakh a month?" — you can answer that. "Is this competitor spending ₹18 lakh a month or ₹27 lakh a month?" — you cannot answer that reliably with this method.

Method 2: Landing page traffic reverse-engineering

More effort, tighter accuracy. Instead of estimating impressions and CPMs directly, you estimate the traffic Meta ads are driving to the competitor's landing pages, then reverse-engineer spend from the traffic × CPC (cost per click) ratios that Meta ads for that specialty typically produce.

Traffic estimation uses tools like SimilarWeb, Semrush Traffic Analytics, or ICG's own referrer-log inference. You isolate the paid-social channel component (Facebook/Instagram referrers), estimate CPC based on healthcare-vertical benchmarks (typically ₹8 to ₹80 depending on specialty, urgency, and city), and back into spend.

Method 2's accuracy band is roughly plus-or-minus 25 percent, meaningfully tighter than Method 1. But it requires access to third-party traffic-estimate tools (SimilarWeb Enterprise starts at USD 5,000 per year) and it fails if the competitor sends Meta traffic to WhatsApp or a phone number instead of a trackable landing page. Roughly 60 percent of Indian healthcare Meta ad traffic in 2026 goes to WhatsApp Click-to-Chat destinations. For those brands, Method 2 does not work.

Method 3: Hybrid — ad volume × run length × format weighting

Prism Spy Comparative Insights showing longest-running creatives, highest quality ads, and format mix distribution across tracked healthcare competitors">

The method Prism Spy uses. Ad volume alone (Method 1) treats a 3-day throwaway test the same as a 200-day proven converter. It shouldn't. A brand running 12 ads where 9 have been active more than 90 days is spending a lot more than a brand running 12 ads where all were launched in the past week. Run length is a proxy for confidence, and confidence is a proxy for continued spend.

The hybrid method weighs each active ad by three factors: run length (days active, capped at 365), format multiplier (video ads cost more per impression than static image ads, typically 1.4x to 1.8x depending on placement), and estimated impressions per day (derived from format × placement × specialty benchmarks). Sum across all active ads on the brand and you get a monthly spend estimate.

Accuracy band for the hybrid method sits at roughly plus-or-minus 20 percent when calibrated against the small sample of brands where actual spend has been disclosed (Prism Spy calibrates monthly against pharma issue-ad disclosures and against clients who share their own MCC data for benchmarking accuracy). Better than Method 1, comparable to Method 2, and works for WhatsApp-first advertisers where Method 2 fails.

Side-by-side comparison

Meta Catalyst IQ long-term comparison view charting Meta Ads performance across quarters with spend, CPQL and volume overlaid" width="1200" height="675" loading="lazy" decoding="async" style="width:100%;height:auto;display:block;">

What to do with the estimate once you have it

Three uses matter in a healthcare agency context. First, share-of-voice benchmarking — is your client spending 12 percent of the specialty's total ad spend in a city, or 3 percent? That answer tells you whether the growth blocker is budget or creative. Second, budget defence — when a hospital marketing committee asks "why are we spending ₹6 lakh a month on Meta?", an estimate that the top three competitors in the city are each spending ₹9 to ₹14 lakh a month reframes the conversation. Third, competitor spike detection — if a competitor's estimated spend jumps 60 percent month-on-month, they are running a campaign or a launch. You want to know before they eat your CPQL.

Where estimates should not be used: exact benchmarking claims in client decks ("Competitor A spent ₹17.3 lakh last quarter"), decisions that require rupee-level accuracy, or any regulatory or legal filing. Estimates are directional intelligence, not audit-grade financials. Present them with the accuracy band visible.

How the estimation layer connects to the rest of the stack

Spend estimation is one input among several in a full competitor intelligence workflow. Prism Spy pairs it with creative quality scoring, run-length ranking, offer surveillance, and format-mix trending — all of which get pulled into the same Monday-morning briefing document. For agencies running full-service healthcare growth engagements, the spend estimate becomes the anchor for share-of-voice conversations that plug directly into the Meta Catalyst IQ performance layer and the broader healthcare social media marketing agency roadmap. Standalone, the spend estimate is useful. Wired into the rest of the intelligence, it becomes the number that changes conversations with clients.

Frequently asked